Briakinumab Biosimilar - Research Grade

CD30

5mg/ml

Human IgG1 (E356D/M358L)-kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human CD30

Blue ice

CD30 is a TNF-receptor-family member expressed on activated lymphocytes and a hallmark of certain lymphomas, making it a focus of haematology research. Offered as an unconjugated, non-therapeutic analog of briakinumab, this recombinant anti-human CD30 reagent is for research use only (RUO). It is produced to in vivo standards with a low-endotoxin profile and available in scalable milligram (mg) to gram (g) lots appropriate for heavy-usage and high-throughput facilities. Applications include functional assays, lymphocyte-activation and binding studies, defined controls, and in vivo lymphoma models, with reproducible performance to support extended research programmes.

ICH3002

https://www.imgt.org/mAb-DB/